Osmetech plc
Molecular diagnostics and critical care diagnostic instrumentation
Osmetech plc is an international genetic diagnostics business focused on providing cutting-edge, cost-effective molecular diagnostic technologies and tools that enable a broader range of hospitals and laboratories to offer molecular diagnostic services for improved patient care.
Gordon Hall (Chairman)
James White (Chief Executive Officer)
Gordon Kuenster (Non-executive Director)
David Sandilands (Chief Financial Officer)
Alfred Marek (Executive Director and President of Critical Care Division)
Bruce Huebner (President of CMS)
Geoff McKinley (VP Molecular Diagnostics R&D and Business Development)
No.1 Liverpool Street
London
EC2M 7QD
UK
Phone: +44 (0)20-7849-6027
Fax: +44 (0)20-7956-2001
Related patents
- Semiconducting organic polymers for gas sensors
- Semiconducting organic polymer gas sensor
- Fuzzy neural networks
- Detection of conditions by analysis of gases or vapours
- Detection of medical conditions by analysis of exhaled gasses or vapours
- Gas sensor
- Sensor interrogation
- Conducting organic polymers
- Detection of conditions by analysis of gases or vapors
- Microorganism analysis means
- Apparatus and methods for gas sampling
- A method for batch manufacturing sensor units
- Method and apparatus for detecting microorganisms
- Method for detecting microorganisms
- Detection of conditions by analysis of gases or vapours
- Hand-held apparatus and method
- Detection of bacterial vaginosis
- Detection of infections in liquid samples by detecting fatty acids present in the headspace associated with the liquid sample
Related news
- FDA Clears Osmetech’s Warfarin Sensitivity Test and New eSensor® XT-8 Platform
- Preliminary Results for the Year Ended 31 December 2007
- Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
- Osmetech Licenses Warfarin Biomarker from Marshfield Clinic
